Progress in adult ALL: incorporation of new agents to frontline treatment
Author:
Affiliation:
1. Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR; and
2. University of Chicago Medicine, Chicago, IL
Abstract
Publisher
American Society of Hematology
Subject
Hematology
Link
http://ashpublications.org/hematology/article-pdf/2017/1/28/1250033/hem00004.pdf
Reference67 articles.
1. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children’s Cancer Group and Cancer and Leukemia Group B studies;Stock;Blood,2008
2. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols;Barry;J Clin Oncol,2007
3. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials;Ramanujachar;Pediatr Blood Cancer,2007
4. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study;Huguet;J Clin Oncol,2009
5. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia;DeAngelo;Leukemia,2014
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia;Current Medical Science;2024-04
2. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-02-01
3. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis;Seminars in Diagnostic Pathology;2023-11
4. Cancer-associated fibroblasts in acute leukemia;Frontiers in Oncology;2022-12-19
5. Targeting cancer-associated glycans as a therapeutic strategy in leukemia;All Life;2022-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3